1-Methyl-D-tryptophan Reduces Tumor CD133+ cells, Wnt/β-catenin and NF-κβp65 while Enhances Lymphocytes NF-κβ2, STAT3, and STAT4 Pathways in Murine Pancreatic Adenocarcinoma

IDO1: An important immunotherapy target in cancer treatment

(2017) Fangxuan Li et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Dendritic Cell-Based Immunotherapy: State of the Art and Beyond

(2016) K. F. Bol et al.   CLINICAL CANCER RESEARCH

Synergistic antitumor effect with indoleamine 2,3-dioxygenase inhibition and temozolomide in a murine glioma model

(2016) Mitsuto Hanihara et al.   JOURNAL OF NEUROSURGERY

Role of indoleamine 2,3-dioxygenase in an inflammatory model of murine gingiva

(2016) X. Qin et al.   JOURNAL OF PERIODONTAL RESEARCH

Indoleamine 2,3 dioxygenase as a prognostic and follow-up marker in melanoma. A comparative study with LDH and S100B

(2016) M.V. de Lecea et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

IDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and Tolerance

(2016) David H. Munn et al.   TRENDS IN IMMUNOLOGY

Tumor indoleamine 2,3-dioxygenase (IDO) inhibits CD19-CAR T cells and is downregulated by lymphodepleting drugs

(2015) Soranobu Ninomiya et al.   BLOOD

Research progress of indoleamine 2,3-dioxygenase inhibitors

(2015) Tianze Jiang et al.   Future Medicinal Chemistry

Substrate Oxidation by Indoleamine 2,3-Dioxygenase

(2015) Elizabeth S. Booth et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Inhibition of the NF-κB Signaling Pathway by a Novel Heterocyclic Curcumin Analogue

(2015) Anna-Maria Katsori et al.   MOLECULES

Targeting the indoleamine 2,3-dioxygenase pathway in cancer

(2015) Yong Wha Moon et al.   Journal for ImmunoTherapy of Cancer

Histochemical Detection of Collagen Fibers by Sirius Red/Fast Green Is More Sensitive than van Gieson or Sirius Red Alone in Normal and Inflamed Rat Colon

(2015) Cristina Segnani et al.   PLoS One

Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancer

(2014) George C. Prendergast et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Reversibility of Effectively Treated Chemotherapy-Related Heart Failure: Raising Our Awareness and a Call to Action for Cardiology

(2014) Daniel J. Lenihan   JOURNAL OF CARDIAC FAILURE

Cross-presentation of viral antigens in dribbles leads to efficient activation of virus-specific human memory t cells

(2014) Wei Ye et al.   Journal of Translational Medicine

Trial watch: IDO inhibitors in cancer therapy

(2014) Erika Vacchelli et al.   OncoImmunology

Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine

(2013) Daniel D. Von Hoff et al.   NEW ENGLAND JOURNAL OF MEDICINE

Autologous lysate-pulsed dendritic cell vaccination followed by adoptive transfer of vaccine-primed ex vivo co-stimulated T cells in recurrent ovarian cancer

(2013) Lana E. Kandalaft et al.   OncoImmunology

Role of the Wnt-β-catenin signaling pathway in melanoma-mediated dendritic cell tolerization

(2013) Alisha Holtzhausen et al.   Journal for ImmunoTherapy of Cancer

Persistent infectious diseases say – IDO. Role of indoleamine-2,3-dioxygenase in disease pathogenesis and implications for therapy

(2012) Heidi Barth et al.   CRITICAL REVIEWS IN MICROBIOLOGY

Turn Off the IDO: Will Clinical Trials Be Successful?: Figure 1.

(2012) Sergey V. Novitskiy et al.   Cancer Discovery

Structure and Reaction Mechanism in the Heme Dioxygenases

(2011) Igor Efimov et al.   BIOCHEMISTRY

Indoleamine 2,3-Dioxygenase Expression in Human Cancers: Clinical and Immunologic Perspectives

(2011) J. Godin-Ethier et al.   CLINICAL CANCER RESEARCH

Immunotherapeutic Suppression of Indoleamine 2,3-Dioxygenase and Tumor Growth with Ethyl Pyruvate

(2010) A. J. Muller et al.   CANCER RESEARCH

IDO Activates Regulatory T Cells and Blocks Their Conversion into Th17-Like T Cells

(2009) B. Baban et al.   JOURNAL OF IMMUNOLOGY